Anthony Andrews (36) believes that a new device, called a subcutaneous implantable defibrillator, will give him a chance at a longer life.

At 36 years old, Anthony Andrews has struggled with health problems for most of his adult life. Currently on dialysis for kidney failure, Andrews also has a complex family history of heart disease, as well as vascular issues. As a result, Andrews has had no options for a life-saving intervention should a cardiac emergency occur – until now.

In November 2012, he became the first person in New England to receive a new type of heart defibrillator, or ICD, approved by the U.S. Food and Drug Administration just two months ago.

The cardiac device, called a subcutaneous implantable defibrillator (S-ICD), is implanted under the skin and delivers an electric shock to the heart to treat an abnormally rapid heartbeat. Unlike a traditional ICD, which involves one or more insulated wires that run from the device through a patient’s vein to the lower chamber of the heart, the S-ICD does not require access to a patient’s heart or blood vessels.

Instead, the insulated wire, or lead, is placed under the skin, which is especially important for patients like Andrews, who are not good candidates to receive a traditional ICD because of complicated vascular structure, scarring, or other health issues.

“For a subset of our patients who have life-threatening arrhythmias but are not eligible for a traditional ICD, this has the potential to save their lives,” says Dr. Laurence Epstein, Chief of the Cardiac Arrhythmia Service at Brigham and Women’s Hospital (BWH). He believes that 10 to 15 percent of his patient population will benefit from the new device.

In October 2012, Andrews learned from his cardiologist, Dr. Bruce Koplan, that he was eligible for the new device. After Koplan performed the surgery, Andrews was up and about later the same day and released the following morning. The device, manufactured by Boston Scientific, will not interfere with Andrews’ dialysis treatment, and unlike a traditional ICD, the risk of infection is minimized. Two additional S-ICD surgeries were performed at BWH the same day.

“This device was created for people like me,” says Andrews, who has received care at BWH since he was born. “I am also a dialysis patient, and the device frees up access to my arms for dialysis treatment. The device will give me a chance at a longer life.”

To learn more about the Cardiac Arrhythmia Service and other cardiac care programs at Brigham and Women’s Hospital, visit the Shapiro Cardiovascular Center.

– Michelle C.

comments (0)